Endoscopy 2023; 55(S 02): S98
DOI: 10.1055/s-0043-1765230
Abstracts | ESGE Days 2023
Oral presentation
Cholangioscopy world 2 22/04/2023, 10:00 – 11:00 Ecocem

PERcutaneous transhepatic cholangioscopy using a new single-operator short CHOLangioscope (PERCHOL): a European feasibility study

Authors

  • E. Perez-Cuadrado-Robles

    1   European Hospital Georges Pompidou, Paris, France
  • S. Phillpotts

    2   University College London Hospitals Nhs Foundation Trust, London, United Kingdom
  • M. Bronswijk

    3   University Hospital Gasthuisberg, Leuven, Belgium
  • C. Cim Conrad

    4   Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
  • C. Binda

    5   Forlì-Cesena Hospitals, AUSL Romagna, Forli, Italy
  • L. Monino

    6   Cliniques universitaires Saint-Luc (UCLouvain), Bruxelles, Belgium
  • K. Basiliya

    2   University College London Hospitals Nhs Foundation Trust, London, United Kingdom
  • M. Hollenbach

    7   Leipzig University, Leipzig, Germany
  • A. Papaefthymiou

    2   University College London Hospitals Nhs Foundation Trust, London, United Kingdom
  • H. Alric

    1   European Hospital Georges Pompidou, Paris, France
  • L. Quénéhervé

    8   CHU Brest, Brest, France
  • A. Di Gaeta

    1   European Hospital Georges Pompidou, Paris, France
  • P. Mathieu

    9   Hospices Civils de Lyon – HCL, Lyon, France
  • A. Khani

    10   Royal Free Hospital, London, United Kingdom
  • D. Lorenzo

    11   Hospital Beaujon AP-HP, Clichy, France
  • T. Moreels

    12   Cliniques universitaires Saint-Luc (UCLouvain), Avenue Hippocrate, Brussels, Belgium
  • G. Rahmi

    1   European Hospital Georges Pompidou, Paris, France
  • F. Carlo

    5   Forlì-Cesena Hospitals, AUSL Romagna, Forli, Italy
  • F. Prat

    11   Hospital Beaujon AP-HP, Clichy, France
  • W. Laleman

    3   University Hospital Gasthuisberg, Leuven, Belgium
  • C. Cellier

    1   European Hospital Georges Pompidou, Paris, France
  • S. Van der Merwe

    3   University Hospital Gasthuisberg, Leuven, Belgium
  • G. Webster

    13   University College London Hospitals Nhs Foundation Trust, Euston Road, London, UK, London, United Kingdom
  • M. Ellrichmann

    4   Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
 
 

    Aims The aim was to assess the feasibility and safety of percutaneous endoscopic cholangioscopy using a new short, dedicated device.

    Methods This is an observational, multicenter retrospective study. All patients who underwent percutaneous cholangioscopy using Spyglass Discover in 2020-2022 were included.

    The clinical success, defined as the complete duct clearance or the performance of at least one cholangioscopy-guided biopsy, was assessed. The histopathological accuracy was assessed. The technical success and the adverse event rate were considered.

    Results Fifty-one patients (60.2±15.9 years, 45.1% male) were included. Most presented with an altered anatomy (n=40, 78.4%) and biliary stones (n=34, 66.7%). The technique was mainly wire-guided (n=44, 86.3%) through a percutaneous sheath (n=36, 70.6%) at a median of 8.5 days from percutaneous drainage.

    Cholangioscopy-guided electrohydraulic lithotripsy was performed in 29 cases (56.9%), combined with a retrieval basket (n=8, 27.6%). The clinical success was 96.6% requiring a median of 1 session. Seventeen patients (33.3%) underwent cholangioscopy-guided biopsies, with a clinical success and accuracy of 100% and 94.1%.

    Overall, the technical success and adverse event rates were 100% and 7.6% in a median follow-up of 7 months.

    Conclusions Percutaneous endoscopic cholangioscopy is effective and safe, requiring a low number of sessions for achieving duct clearance or accurate diagnosis.


    Conflicts of interest

    EPCR is consultant of Boston Scientific

    Publication History

    Article published online:
    14 April 2023

    © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany